A detailed history of Legacy Capital Group California, Inc. transactions in Twist Bioscience Corp stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 27,089 shares of TWST stock, worth $999,313. This represents 0.41% of its overall portfolio holdings.

Number of Shares
27,089
Previous 27,018 0.26%
Holding current value
$999,313
Previous $1.33 Billion 8.08%
% of portfolio
0.41%
Previous 0.48%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$36.72 - $58.88 $2,607 - $4,180
71 Added 0.26%
27,089 $1.22 Billion
Q2 2024

Jul 22, 2024

SELL
$27.95 - $53.0 $33,623 - $63,759
-1,203 Reduced 4.26%
27,018 $1.33 Billion
Q1 2024

May 07, 2024

BUY
$32.28 - $41.5 $910,973 - $1.17 Million
28,221 New
28,221 $968 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.08B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Legacy Capital Group California, Inc. Portfolio

Follow Legacy Capital Group California, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Capital Group California, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Capital Group California, Inc. with notifications on news.